A Dutch phase III randomized multicenter trial: whole brain radiotherapy vs. stereotactic radiotherapy for 4-10 brain metastases

Dianne Hartgerink,Anna Bruynzeel,Danielle Eekers,Ans Swinnen,Coen Hurkmans,Ruud Wiggenraad,Annemarie Swaak-Kragten,Edith Dieleman,Peter-Paul van der Toorn,Bing Oei,Lieneke van Veelen,Joost Verhoeff,Frank Lagerwaard,Dirk de Ruysscher,Philippe Lambin,Jaap Zindler

Neuro-oncology advances（2021）

引用 19|浏览15

暂无评分

摘要

In patients with 4-10 BM, SRS alone resulted in 1-year survival for 57% of patients while maintaining quality of life. Due to the premature closure of the trial, no statistically significant differences could be determined.

查看译文

关键词

brain metastases,quality of life,stereotactic radiotherapy,whole brain radiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要